[HTML][HTML] 高危因素对英夫利西单抗治疗克罗恩病疗效的影响
王迪， 李林珍， 崔秀芳， 张丽， 吴莎莎… - 南京医科大学学报(自然 …, 2021 - jnmu.njmu.edu.cn
… and clinical characteristics of inflammatory bowel disease in a … Prediction of short ⁃ and
medium ⁃term efficacy of biosimilar … Can we predict the efficacy of anti ⁃TNF ⁃α agents?[J].Int J …
medium ⁃term efficacy of biosimilar … Can we predict the efficacy of anti ⁃TNF ⁃α agents?[J].Int J …
[HTML][HTML] 英夫利西单抗在炎症性肠病中的应用: 现状与展望
李彦琴， 刘丹平 - Advances in Clinical Medicine, 2022 - hanspub.org
… inflammatory bowel diseases with unknown etiology and pathogenesis. These include ulcerative
colitis (UC), Crohn disease … 治疗药物监测(Therapeutic drug monitoring, TDM)有助于原发…
colitis (UC), Crohn disease … 治疗药物监测(Therapeutic drug monitoring, TDM)有助于原发…
英夫利西单抗用于克罗恩病患者的治疗药物监测研究进展
朱扣柱， 王燕， 缪丽燕 - 中国药房, 2023 - journal.china-pharmacy.com
… This paper reviews the pharmacokinetic characteristics of IFX,… Prediction of short- and
medium-term efficacy of biosimilar infli… anti-TNF drug concentrations in inflammatory bowel …
medium-term efficacy of biosimilar infli… anti-TNF drug concentrations in inflammatory bowel …
生技仿製藥規範與公費報銷政策對藥廠經營策略之影響—美國, 歐洲與日本制度之比較分析
J Yamaguchi - 2014 - tdr.lib.ntu.edu.tw
… in biosimilar regulations and reimbursement policies, using the US, EU, and Japan
pharmaceutical … Based on the comparison of these features, the relative degree of potential …
pharmaceutical … Based on the comparison of these features, the relative degree of potential …
IS-S3-1 指_ G Advance in the treatment of IBD
K Matsuoka - jstage.jst.go.jp
… ics (infliximab, infliximab biosimilar, adalimumab, … inflammatory bowel disease (IBD)has
dramatically improved in the past decades, especially by using biologic agents such as anti-TNF…
dramatically improved in the past decades, especially by using biologic agents such as anti-TNF…
[PDF][PDF] Qualitative Evaluation and Bioactivity Assessment of Polygonum bistorta (拳參)
… review, the differences between some macroscopic features of Bistotae Rhizoma and that of
its counterfeit are reviewed… hot topic of Biosimilars, which is transforming the industry of drug …
its counterfeit are reviewed… hot topic of Biosimilars, which is transforming the industry of drug …
[PDF][PDF] 阿达木单抗治疗强直性脊柱炎的临床应用进展
赵宇晗， 张凌凡， 李智慧， 杨也， 倪娜， 王俊龙 - 世界临床药物, 2020 - jwph.com.cn
… : another paradoxical reaction to anti-TNF therapy?[J]. J … treated with adalimumab-a new
side effect after 15 years of … Drug immunogenicity in patients with inflammatory arthritis and …
side effect after 15 years of … Drug immunogenicity in patients with inflammatory arthritis and …